Glenmark Pharmaceuticals is currently trading at Rs. 538.00, up by 5.95 points or 1.12 % from its previous closing of Rs. 532.05 on the BSE.
The scrip opened at Rs. 535.00 and has touched a high and low of Rs. 539.80 and Rs. 530.00 respectively. So far 17271 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 612.00 on 12-Jul-2013 and a 52 week low of Rs. 458.00 on 28-Mar-2013.
Last one week high and low of the scrip stood at Rs. 548.70 and Rs. 526.45 respectively. The current market cap of the company is Rs. 14559.41 crore.
The promoters holding in the company stood at 48.31 % while Institutions and Non-Institutions held 40.86 % and 10.83 % respectively.
Glenmark Pharmaceuticals and Glenmark Generics Inc., USA (Glenmark) has confirmed that Cephalon Inc. has filed a patent infringement suit on December 26, 2013 in the US District Court for the District of Delaware seeking to prevent Glenmark from commercializing its Abbreviated New Drug Application (ANDA) Bendamustine Hydrochloride product, their generic version of Treanda, prior to expiration of the Orange Book patents. This lawsuit was filed under the provisions of the Hatch-Waxman Act.
Bendamustine is indicated for the treatment of patients with Chronic Lymphocytic Leukemia. This ANDA has been filed from Glenmark’s Argentina lyophilized injectable facility. For the twelve-month period ending September 2013, Treanda achieved sales of $659 million according to IMS Health.
Glenmark Generics (GGL) is a subsidiary of Glenmark Pharmaceuticals (Glenmark) and aims to be a global integrated Generic and API leader. GGL, has an established presence in North America and developing an EU presence, which primarily sells its FDF products in the United States (US) and the European Union (EU), as well as its oncology FDF products in South America. The Company supplies APIs to customers in approximately 80 countries, including the US, various countries in the EU, South America and India.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1777.65 |
Dr. Reddys Lab | 1194.55 |
Cipla | 1465.65 |
Lupin | 2043.30 |
Zydus Lifesciences | 944.25 |
View more.. |